Korean J Nephrol.  2000 Sep;19(5):934-942.

Mizoribine in Living Donor Kidney Transplantation: Twenty Four-week Results of A Single Center, Pre-randomized, Open-label, Prospective, Comparative, Phase III Study

Affiliations
  • 1Division of Nephrology, University Hospital, Daegu, Korea.

Abstract

No abstract available.


MeSH Terms

Humans
Kidney Transplantation*
Kidney*
Living Donors*
Prospective Studies*
Full Text Links
  • KJN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr